PHILADELPHIA, March 10, 2022 /PRNewswire/ -- Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection ...
Clario has partnered with Strados Labs to offer its customers the RESP Biosensor System, an advanced technological innovation for the at-home capture of lung sounds. The revolutionary device enables ...
GOLDEN VALLEY, MN, USA, August 6, 2024 /EINPresswire.com/ -- Delve Health, a leader in decentralized clinical trial solutions, is excited to announce a strategic ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Funds will be used to expand its pipeline of smart sensor ...
Strados Labs announced it received FDA clearance for home use of its smart sensor platform for respiratory health, according to a press release. The RESP Smart Sensor Platform provides early, remote ...
In its second respiratory-focused deal of the month, Clario is partnering with Strados Labs to use its FDA-approved monitoring device for clinical trials. Under the agreement, Philadelphia-based ...
PHILADELPHIA, May 3, 2022 /PRNewswire/ -- Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and ...
Starting in early 2023 the biopharmaceutical company will use the Strados RESP™ Biosensor to remotely monitor cough and crackles in patients at home PHILADELPHIA, Jan. 26, 2023 /PRNewswire/ -- Strados ...
PHILADELPHIA, Nov. 18, 2021 /PRNewswire/ -- Strados Labs, a medical technology company harnessing the power of smart sensors to aid in early detection and predictions of worsening diseases for ...
Investors including SOSV, Cultivate(MD), Wavemaker360 Health, Blu Venture Investors and Broad Street Angels are backing Strados Labs LLC with $4.5 million. The pre-series A funding will be used to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results